Xuejun Wang

发表

Novel use of clinical drugs: Deubiquitinase inhibitor auranofin and disulfiram show synergistic anti-tumor effects in vitro and in vivo

Jinbao Liu, Hongbiao Huang, Ningning Liu, 2016 .

Novel use of old drug: Anti-rheumatic agent auranofin overcomes imatinib-resistance of chronic myeloid leukemia cells.

Jinbao Liu, Xuejun Wang, Xin Chen, 2014, Cancer cell & microenvironment.

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases

D. Zang, Jinbao Liu, Xiaofen Li, 2017, Oncotarget.

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

Quentin Liu, D. Zang, Jinbao Liu, 2014, Oncotarget.

A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers

Xiaolan Zhang, Jinbao Liu, Hongbiao Huang, 2017, Oncotarget.

Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane

D. Mutch, Yang Su, W. Hawkins, 2016, Oncotarget.

Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells

Xiaolan Zhang, Jinbao Liu, Xuejun Wang, 2018, Cellular Physiology and Biochemistry.

Investigation of the Definition of De Novo Oligometastatic Nasopharyngeal Carcinoma: A Retrospective Study

Yawei Yuan, Xuejun Wang, Weijun Zhang, 2021, Journal of oncology.

Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo

D. Zang, Jinbao Liu, Xiaofen Li, 2015, Oncotarget.

Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation

D. Zang, Jinbao Liu, Hongbiao Huang, 2017, Cell Death & Disease.

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms

D. Zang, Jinbao Liu, B. Carter, 2016, Journal of Hematology & Oncology.

2-tert-butyl-1,4-benzoquinone Induces Apoptosis in Chronic MyeloidLeukemia Cells Resistant to Imatinib via Inducing Caspase-Dependent Bcr-Abl Downregulation

Jinbao Liu, B. Carter, Xiaofen Li, 2014 .

2-tert-butyl-1,4-benzoquinone Induces Apoptosis in Chronic Myeloid Leukemia Cells Resistant to Imatinib via Inducing Caspase-Dependent Bcr-

Jinbao Liu, B. Carter, Xiaofen Li, 2014 .

Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo.

Q. Dou, Jinbao Liu, P. Zhou, 2013, Cell reports.

Ubiquitin Carboxyl-Terminal Hydrolase L1 of Cardiomyocytes Promotes Macroautophagy and Proteostasis and Protects Against Post-myocardial Infarction Cardiac Remodeling and Heart Failure

Jinbao Liu, Hua Zhu, Faqian Li, 2022, Frontiers in Cardiovascular Medicine.

Sanggenon C decreases tumor cell viability associated with proteasome inhibition.

Q. Dou, Jinbao Liu, P. Zhou, 2011, Frontiers in bioscience.

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Ping Zhou, Wenbin Song, Li Xu, 2014, Oncotarget.

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases

Q. Dou, Jinbao Liu, P. Zhou, 2014, Scientific Reports.

Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition

D. Zang, Jinbao Liu, Xiaofen Li, 2015, Scientific Reports.

Cutaneous Metastasis as the First Presentation of Non-Small-Cell Lung Cancer with a BRAF Mutation: A Case Report

Yawei Yuan, Xuejun Wang, Weijun Zhang, 2020, OncoTargets and therapy.

Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor

Jinbao Liu, Hongbiao Huang, Ningning Liu, 2017, Cell Death & Disease.

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy

D. Zang, Jinbao Liu, Zhiming He, 2016, Biochemical pharmacology.

A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment

D. Zang, Jinbao Liu, Xiaofen Li, 2016, Scientific Reports.

A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy

D. Zang, Q. Dou, Jinbao Liu, 2016, Oncogene.

S14-Phosphorylated RPN6 Mediates Proteasome Activation by PKA and Alleviates Proteinopathy

Jinbao Liu, N. Parajuli, Xuejun Wang, 2023, Circulation research.